Figure 1. Examples of Colorectal Tumors Arising in FAP and HNPCC Patients
The left panel is a small portion of the colon from an FAP patient as viewed through the colonoscope, illustrating the multiple benign tumors (adenomas) characteristic of FAP (arrows). The right panel shows a single cancer from an HNPCC patient after surgical resection.
number of colorectal tumors (Nagase and Nakamura, encoding secreted phospholipase A2 (sPLA2) (MacPhee et al., 1995) . 1993). On the other hand, patients with identical mutations can develop dissimilar clinical features. For example, some patients with identical truncating mutations develop features of Gardner's syndrome (mandibular
Hereditary Versus Environment
The identification of MOM1 as a phospholipase-encodosteomas and desmoid tumors) while others do not (Nishisho et al., 1991) . Similarly, only a small number ing gene provides an excellent example of how genetic studies can lead to clues about the interaction between of patients within any kindred develop brain tumors, hepatoblastomas, or thyroid cancers, even though there heredity and environment. As depicted in Figure 3 , hereditary cancers clearly have a central genetic compois a clear predisposition to these tumors associated with germline APC mutations (Giardiello, 1995; nent, but there are important differences between them and classic genetic diseases such as cystic fibrosis and al., 1995) . The complex relationship between genotype and phenotype is also apparent in other hereditary canmuscular dystrophy. In the latter cases, the genetic alterations lead to disease in a straightforward and reprocer predisposition syndromes, including those associated with breast cancer (Szabo and King, 1995) . Whether ducible fashion. Certain forms of diabetes and atherosclerosis present a more complex scenario, in which these phenotypic differences result from environmental influences or modifying genes is not known.
disease severity is significantly influenced by diet and metabolic interventions. Cancer is even more complex. Perhaps the most clear-cut example of the distinction between phenotype and APC genotype is observed in Patients with germline mutations are predisposed to cancer, but will not necessarily be afflicted with disease. MIN mice. These mice develop multiple intestinal adenomas and have a truncating mutation of the murine APC Additional mutations are required, and the rate of mutation can obviously be affected by environmental factors. gene (mAPC) at a position similar to that found in many FAP patients (Su et al., 1992) . Depending on the inbred In addition to affecting mutation rates, the diet may affect other cellular processes, like apoptosis, which mouse strain harboring this mutation, however, the number of polyps varies significantly. Linkage analysis has could limit tumor initiation or progression (Bellamy et al., 1995) . demonstrated that a single locus (MOM1, for modifier of MIN) on mouse chromosome 4 accounts for much of Epidemiologic studies strongly suggest that the diet can influence colorectal cancer incidence (Giovannucci this difference between strains (Dietrich et al., 1993) . Recently, the MOM1 gene has been identified as that and Willett, 1994) . However, human diets are so complex . c Based on analysis of 12 colorectal polyps . d Based on analysis of 23 colorectal cancer cell lines . e Based on 174 mutations (summarized in Nagase and Nakamura, 1993 Functional domains and sequence features: amino-terminal residues 1 to 171 are sufficient for oligomerization . This oligomerization is thought to be mediated by the heptad repeats indicated in pink on the sequence features map. APC binds to ␤-catenin through two motifs, the first comprising three 15 amino acid repeats indicated in black on the sequence features map and located between residues 1020 and 1169 Su et al., 1993) . A second region, comprising "20 aa repeats" (indicated in red on the sequence feature map and within residues 1324 to 2075; Groden et al., 1991) binds to ␤-catenin and also acts as substrate for GSK phosphorylation (Munemitsu et al., 1995; Rubinfeld et al., 1996) . Phosphorylation is thought to occur at SXXXS sites within the 20 aa repeats (Rubinfeld et al., 1996) . When transiently overexpressed, full-length APC decorates the microtubule cytoskeleton. The carboxyl terminus of APC is required for this association and residues 2130 to 2843 are sufficient (Munemitsu et al., 1994; Smith et al., 1994) . Two proteins have been shown to associate with the carboxyl terminus of APC. Residues 2560 to 2843 are sufficient to bind EB1, a highly conserved 30 kDa protein of unknown function (Su et al., 1995) . Residues 2771 to 2843 are sufficient to bind DLG, a human homolog of the Drosophila Disc large tumor suppressor gene (Matsumine et al., 1996) ; the three carboxy-terminal residue motif TXV (indicated in green on the sequence features map) probably mediates this binding. Expression of full-length APC in colorectal cancer cell lines results in apoptosis, but the regions required for this activity have not been precisely defined (Morin et al., 1996) . Residues 453 to 767 contain 7 copies of a repeat consensus found in the Drosophila segment polarity gene product armadillo, as indicated in turquoise and residues 2200 to 2400 correspond to a basic region, indicated in blue (Groden et al., 1991) . Disease map: the location of truncating APC mutations has been shown to correlate with the extent of colonic and extra-colonic manifestations. Truncating mutations prior to codon 157 are associated with a reduced number of colorectal polyps (Spirio et al., 1993) whereas the majority of mutations are associated with more pronounced polyposis and occur between codon 169 and 1600 (Nagase and Nakamura, 1993) . Mutation in codons 463 to 1387 are associated with congenital hypertrophy of the retinal pigment epithelium (CHRPE) (Olschwang et al., 1993) . Mutations in codons 1403 to 1578 have been associated with Gardner's Syndrome, in which an increased incidence of extra-colonic manifestation is observed (Davies et al., 1995) .
that it has been difficult to determine which dietary comcan prevent tumor formation and even cause regression of existing colorectal tumors in both man and mouse ponents are responsible for this modulation. The discovery of MOM1 supports the idea that lipids are among (e.g., Giardiello et al., 1993; Boolbol et al., 1996) . As sulindac inhibits the cyclooxygenases that metabolize the critical dietary components. The lipid content of diets varies dramatically, perhaps explaining geothe lipid arachidonic acid, it is possible that genetic studies of MOM1, epidemiologic studies correlating cographic differences in colorectal cancer incidence and the higher rate of colorectal cancer associated with diets lorectal cancer incidence with diet, and chemopreventative studies with NSAID are all linked through lipids, containing large amounts of red meat (Giovannucci and Willett, 1994) . Moreover, it has been shown that nonsteparticularly arachidonic acid. roidal anti-inflammatory drugs (NSAID) such as sulindac Rare Syndromes, Common Cancers, and Gatekeepers Studies of relatively rare inherited cancer predisposition syndromes like FAP have proved rewarding not only in their own right but also because the genes identified through such studies have been shown to play a role in the more common "sporadic" (i.e., nonfamilial) cancers of the same type (Table 1) . For example, germline mutations of the APC gene cause FAP, a syndrome that accounts for <1% of colorectal cancers in the United States. But once APC was discovered, it was found that somatic mutations of APC occur in the great majority of sporadic colorectal tumors (Miyoshi et al., 1992; Powell et al., 1992) . In the latter cases, APC mutations occur in single colonic epithelial cells, resulting in truncations of the APC protein identical to those observed in FAP patients.
Truncation of the APC gene may not be absolutely required for colorectal tumorigenesis, as ‫%51ف‬ of colorectal cancers apparently synthesize only full-length APC protein . Likewise, APC muta- The left panel shows a group of normal colonic crypts in cross section. Note that the epithelial cells are precisely lined up along the basement membrane and that there is great uniformity among the glands. The center panel shows the morphology typical of a hyperplastic lesion. Individual cells are morphologically normal, but the increased number of cells in the crypts promotes crowding and mucosal folding, resulting in a saw-toothed appearance. The right panel shows morphology typical of a dysplastic ACF or adenoma. Note the increased nuclear/cytoplasmic ratio, the lack of uniform architecture, and the many nuclei that are no longer lined up along the basement membrane.
such tumors result from mutations of APC that are undehave no physiologic effect. In contrast, the RAS protein is expressed in normal colonic epithelium, and mutatectable by standard methods or from mutations in other genes that encode regulators or mediators of APC functions of RAS frequently occur in colonic tumors as they progress (Vogelstein et al., 1988; Shibata et al., 1993) . tion is an important area for future study.
How do APC mutations initiate colorectal tumorigeneSo what happens if a mutation of RAS occurs in a normal colonic epithelial cell? Interestingly, such mutations do sis? Of the 100,000 genes in the human nucleus, why does mutation of one, and only one, gene lead to the not appear to lead to colorectal neoplasia . Cells with RAS gene mutations are amazingly development of polyposis? And why do patients with such inherited mutations not develop cancers in other common and form foci of hyperproliferating cells (Pretlow et al., 1993) . But these cells have a normal intracelluorgans, despite the fact that APC is ubiquitously expressed? We speculate that a single gene, APC, acts lar and intercellular organization, unlike the dysplastic cells in the ACF-containing mutant APC genes (Figure as the "gatekeeper" of colonic epithelial cell proliferation and that inactivation of this gatekeeper is required for 4) . Moreover, the hyperplastic cells containing mutant RAS genes, unlike their dysplastic net cellular proliferation. Normally, gatekeeper genes are responsible for maintaining a constant cell number counterparts with mutant APC genes, have little or no potential to form clinically important tumors and may in renewing cell populations, ensuring that cells respond appropriately to situations requiring net cell growth (e.g., eventually regress through apoptosis (Shpitz et al., 1996) . tissue damage). A mutation of the gatekeeper leads to a permanent imbalance of cell division over cell death.
These studies suggest that it is not simply the accumulation of mutations, but rather it is also their order, Conversely, mutations of other genes in the presence of a normal gatekeeper would not lead to a sustainable that determines the propensity for neoplasia, and that only a subset of the genes which can affect cell growth growth perturbation.
Several observations are consistent with this hypothecan actually initiate the neoplastic process. Though APC is expressed ubiquitously, it may function as the gatesis. Inactivation of both alleles of the murine APC gene occurs very early in mouse colon tumor development, keeper only in colorectal epithelium. In other cell types, its function may be redundant or at least expendable, as demonstrated by their occurrence in lesions so small that they can only be observed at the microscopic level and different gene products presumably perform the gatekeeper role. Other potential gate-keepers include (Levy et al., 1994; Luongo et al., 1994) . In the human, too, complete APC inactivation has been found in the the NF1 gene in Schwann cells, the Rb gene in retinal epithelial cells, and the VHL gene in kidney cells (reearliest neoplastic lesions that can be examined . Such lesions, called dysplastic aberrant crypt viewed in Knudson, 1993) . Unfortunately, no gatekeeper has yet been discovered for the cell types accounting foci (ACF), are believed to be the precursors of adenomas.
for the great majority of human malignancies, including those of the lung, breast, prostate, pancreas, brain, and What happens if mutations of other genes involved in colorectal cancer occur before those of APC? Apparbladder. Progress in understanding the pathogenesis of these malignancies will in large part depend on identiently, such mutations do not efficiently initiate the neoplastic process. One example is provided by the tumor fying these gatekeepers. suppressor p53, which is genetically altered in >80% of colorectal cancers (Baker et al., 1990 ). Yet patients with
Gatekeeper Mechanisms How does APC exerts its gatekeeper effect? The APC germline mutations of p53 do not develop polyposis and in fact are not even at high risk to develop colorectal protein is apparently located at the basolateral membrane in colorectal epithelial cells, with expression more cancer (Garber et al., 1991) . Therefore, though it is clear that p53 can play a role in colorectal tumorigenesis, it pronounced as cells migrate up through the crypt column Miyashiro et al., 1995) . Expresis equally clear that it cannot initiate the process in a fashion similar to APC.
sion of wild-type APC in colorectal epithelial cells with APC mutations results in apoptosis, suggesting that It might be argued that the p53 protein is not expressed in normal colorectal epithelium and is presum-APC may control the cell death process (Morin et al., 1996) . Abrogation of such a "death signal" could clearly ably not involved in controlling the normal balance between colonic cell birth and death. Therefore, a mutation alter the precise homeostatic balance required in renewing cell populations. of p53 in an otherwise normal colonic epithelial cell may
The protein encoded by APC consists of 2843 amino acids without strong similarities to proteins of known function (Figure 2 ). The amino-terminal third of APC contains several heptad repeats of the type that mediate oligomerization by a coiled-coil structure . These regions may mediate homo-oligomerization between mutant and wild-type proteins, and could theoretically cause a dominant negative effect, though no such effect has been demonstrated biologically.
While the primary sequence of APC has provided few insights into its function, the identification of proteins that interact with APC has yielded tantalizing clues. Two proteins that bind to the C-terminus of APC have been identified. One of these is EB-1, a highly conserved 30 kDa protein of unknown function (Su et al., 1995) . More recently, the carboxy-terminal 72 residues of APC were demonstrated to bind the human homolog of the Drosophila tumor suppressor gene discs large (DLG) (Matsumine et al., 1996) . As virtually all APC mutations result in the loss of the carboxyl terminus of APC protein (Table  1A) , these data suggest that DLG and/or EB1 may be (Bhanot et al., 1996) and the catenin APC Su et al., 1993) . The central associated transcription factors Tcf-3 and Lef-1 (Behrens et al., third of APC harbors two classes of ␤-catenin binding Molenaar et al., 1996) . The biochemical attributes of the prorepeats, one of which is modulated by phosphorylation tein encoded by disheveled (dsh) is not known, and a Drosophila (Figure 2) (Rubinfeld et al., 1996) . Although many mutant homolog of APC has not yet been described. See text for further details.
APC proteins retain some ␤-catenin binding, virtually all mutant APC proteins lack at least one type of ␤-catenin binding repeat.
of HMG box transcription factors (Behrens et al., 1996 ; The ␤-catenin association links APC to two apparently Molenaar et al., 1996) . Taken together, the studies sugdisparate cellular processes. The first process is related gest that APC could work in concert with ZW3/GSK3␤ to cellular adhesion. The catenins were originally identito inhibit ␤-catenin-induced transcriptional activity. The fied as cytoplasmic proteins that bind to cadherins, a importance of this pathway in neoplasia is supported family of calcium-dependent homophilic cell adhesion by the ability of truncated ␤-catenin to transform cells molecules. Several studies have indicated that ␤-catin culture (Whitehead et al., 1995) and the involvement enin is necessary for cadherin-mediated cell adhesion of Wnt signaling in breast tumorigenesis in mice (Nusse (reviewed in Kemler, 1993) . Given that binding of ␤-catand Varmus, 1992) . Given the size of APC, the biological enin to cadherins or to APC is mutually exclusive, it is manifestations of APC inactivation and the number of possible that APC could modulate such adhesion as proteins already known to associate with APC, it is likely part of its gatekeeping function. APC could additionally that APC functions to integrate signals from a variety act as a downstream communicator of adhesion status, of sources, transmitting them to the nucleus through linking cadherin-catenin complexes to other cellular ␤-catenin/Tcf complexes. components.
One general lesson from both the armadillo/␤-catenin The second process involving ␤-catenin has been eluand DLG work is that basic research on the development cidated via studies of the Wingless (Wg) and Wnt signalof invertebrates can illuminate pathways involved in huing pathways in Drosophila and mouse, respectively man tumorigenesis. If the complex signaling pathways ( Figure 5 ). ␤-catenin and Armadillo (the Drosophila mediating tumor suppressor gene functions are ever to homolog of ␤-catenin) have been firmly implicated as be understood, it is likely that the understanding will be signal transducers in these pathways (Gumbiner, 1995) .
heavily indebted to the powerful experimental systems This link was strengthened by the observation that the available in such eukaryotes. The studies of HNPCC APC/␤-catenin complex is physically associated with a described below provide another example of how such second member of this pathway, the ZW3/GSK3␤ probasic research in nonhuman systems has proved pivotal tein kinase (Rubinfeld et al., 1996) . This kinase was found for unraveling the mechanisms underlying colorectal to promote ␤-catenin binding to APC, presumably by neoplasia. phosphorylation of APC Class II binding sites ( Figure  2 ). Epistasis evaluations in Drosophila suggest that Wg
Hereditary Nonpolyposis Colorectal Cancer signaling inhibits ZW3 function, and that active ZW3
HNPCC exemplifies the problems inherent in identifying can inhibit ␤-catenin signaling. Finally, recent studies in the genetic components of diseases that are common Xenopus and mouse suggest that Wnt signaling ultiin the population. Similar challenges have been posed mately results in formation of a heteromeric complex containing ␤-catenin and members of the Tcf/Lef family by breast cancer, melanomas, diabetes, and a variety of . d Based on analysis of 46 adenomas (Young et al., 1993) . e Based on analysis of 273 colorectal cancers Ionov et al., 1993; Thibodeau et al., 1993) . f Based on 33 mutations in 47 kindreds. In addition, a hPMS1 mutation was identified in a single kindred psychiatric conditions. The confounding factors include The third clue was provided not by tumor biologists, but by investigators studying replication fidelity in unichance clusterings mimicking familial forms of disease, the influences of environmental factors (such as diet) cellular organisms (Strand et al., 1993) . These investigators recognized that the microsatellite instability obon penetrance, genetic heterogeneity, and phenocopies (individuals within afflicted families with the same disserved in tumors was similar to that observed in bacteria harboring mutations in mismatch repair (MMR) genes ease but not sharing the causative mutation). In fact, though HNPCC was suspected to be heritable over 80 such as mutS and mutL. Analogous experiments in yeast showed that the microsatellites observed to be unstable years ago, it remained obscure and understudied as a result of these problems. It was only through the susin HNPCC patients were equally unstable in yeast with defective MMR genes, and it was specifically hypothetained efforts of clinical epidemiologists in the last 20 years that HNPCC finally became recognized as a bonasized that HNPCC was caused by hereditary mutations of human homologs of mutS or mutL (Strand et al., 1993) . fide hereditary disease .
Within the last three years, substantial advances in These insights stimulated a search for such human homologs, resulting in the discovery of five human genes understanding the molecular pathogenesis of HNPCC has been made as a result of three related lines of inveslikely to participate in MMR in addition to one serendipitously discovered in 1989 (reviewed in Marra and Botigation. The first was linkage analysis. Following exclusion of candidate gene loci, large kindreds from North land, 1995). That a mutS homolog might be involved in the form of HNPCC linked to chromosome 2 was America, Europe, and New Zealand were evaluated using microsatellite markers distributed throughout the gesuggested by the finding that one such homolog (hMSH2) was located on chromosome 2p (Fishel et al., nome. Tight linkage to either chromosome 2p16 or 3p21 was identified in individual families, providing unambig-1993). Direct evidence that an MMR gene was involved in the disease was provided by the identification of uous evidence that HNPCC was a simple Mendelian disease (Lindblom et al., 1993; Peltomaki et al., 1993) .
germline mutations of hMSH2 in HNPCC kindreds ). This was soon followed by the idenThe second clue was found during attempts to demonstrate allelic losses with the 2p16 microsatellite marktification of mutations of mutL homologs in other HNPCC kindreds. It is currently believed that mutations ers linked to HNPCC susceptibility . Such losses are often found associated with tuin three human MMR genes (hMSH2, hMLH1, and hPMS2) account for the great majority of HNPCC kinmor suppressor loci. In HNPCC tumors, however, new microsatellite alleles, not found in the patient's normal dreds (Table 2) . Strong supporting evidence that mutS and mutL cells, were observed instead of the expected allelic losses. These new alleles were evident in every dinucleogenes played a role in HNPCC was provided by biochemical experiments ; Umar et tide and trinucleotide repeat examined, suggesting a genome-wide instability of the replication or repair of al., 1994). Extracts of tumors with MI were found to be completely deficient in mismatch repair activity in vitro. simple repeated sequences. This form of instability was similar to that first described in a subset of sporadic
The nature of the biochemical defect suggested that one of the initial stages of the MMR process, which (nonfamilial) colorectal cancers (Peinado et al., 1992; Ionov et al., 1993; Thibodeau et al., 1993) . Similarities involve mutS and mutL in bacteria, was defective ( Figure  6 ). Finally, transfer of a human chromosome containing between certain biologic features of the sporadic and hereditary tumors with microsatellite instability (MI) sugthe normal copy of hMLH1 into a human cancer cell line with a mutant hMLH1 gene completely restored MMR gested that related mechanisms might be involved .
activity and reversed the MI (Koi et al., 1994).
to be required. Are normal rates of mutation sufficiently high to account for these accumulated mutations, or do tumor cells have intrinsically high rates of mutation? This question has been debated for years without resolution (Loeb, 1991) . The studies on HNPCC have provided a definitive answer to this question at least in a subset of cancers by demonstrating that mutation rates in tumor cells with MMR deficiency are two to three orders of magnitude higher than in normal cells (Bhattacharyya et al., 1994; Shibata et al., 1994; Eshleman et al., 1995) . HNPCC accounts for 2%-4% of the total colorectal cancers in the Western world . Sporadic tumors with microsatellite instability account for another 13% of the total colorectal cancers (Table 2) , but the molecular mechanisms underlying instability in the sporadic cases are incompletely defined. Some of them result from somatic mutations of the same MMR genes causing HNPCC, while others have mutations of GTBP or MSH3, mismatch repair genes rarely mutated in HNPCC patients Malkhosyan et al., 1996) or in the proofreading domain of polymerase ␦ (da Costa et al., 1995) . In other colorectal tumors with MI, no mutations of repair genes have been identified .
The 85% of colorectal cancers that do not exhibit MI also do not exhibit high rates of mutation in standard assays (Bhattacharyya et al., 1994 ; Eshleman et al., with MI often lose none . At the MSH3, may substitute for GTBP in certain cases . cytogenetic level, these changes are reflected by aneu-(d and e) MutL homologs are then recruited (d) to the complex and ploidy in the former cancers and euploidy in the cases (e) the mismatch is repaired by a process that in bacteria involves with MI (Bocker et al., 1996) . Teleologically, it would an exonuclease, helicase II, DNA polymerase III, single-stranded thus seem that a cancer needs to develop only one binding protein, and DNA ligase (Modrich, 1995) .
type of instability and that gross chromosomal changes provide little selective growth advantage to tumors with Genetic Instability in Cancer mismatch repair deficiency and vice versa. It would also The idea that multiple mutations are necessary for the seem that there are at least two ways for a tumor to development of malignancy is now widely accepted and develop the multiple genetic alterations required for mawell illustrated by studies of colorectal cancer (Figure lignancy: subtle alterations due to the mismatch repair 7). As both alleles of each of the tumor suppressor genes deficiency occur in a minority of cases (those with MI), indicated in the figure are inactivated during this prowhile gross chromosomal alterations occur in the majority. cess, at least seven independent genetic events appear (Huang et al., 1996) , though not identical , series of mutations; MMR deficiency speeds up this process. K-RAS is an oncogene that requires only one genetic event for its activation. The other specific genes indicated are tumor suppressor genes that require two genetic events (one in each allele) for their inactivation. Chromosome 18q21 may contain several different tumor suppressor genes involved in colorectal neoplasia, with DCC, DPC4, and JV18-1 genes proposed as candidates. A variety of other genetic alterations have each been described in a small fraction of advanced colorectal cancers. These may be responsible for the heterogeneity of biologic and clinical properties observed among different cases.
An important implication of these studies relates to
MMR genes and devoid of MMR activity develop surpristhe process of aneuploidy in general. Aneuploidy has ingly few tumors (e.g., Reitmair et al., 1996) . long been observed to be a hallmark of cancer cells.
If humans or mice were continually exposed to mutaBut does aneuploidy simply reflect the numerous extra gens at doses sufficient to induce the grossly elevated cell divisions, abnormal microenvironment, and altered rate of mutation observed in MMR-deficient cells, one physical structure of the cancer cell, or does it represent would have expected a great number of tumors of many a specific physiologic defect that is causally involved in different types. Why isn't MMR deficiency as carcinotumorigenesis? Such distinctions between cause and genic as mutagen exposure? One possibility is that mueffect in properties associated with cancer are extremely tagens are carcinogenic not only because they induce difficult to resolve. The HNPCC work supports the hymutations, but also because they cause substantial celpothesis that aneuploidy is causally related to neoplasia. lular death with consequent tissue regeneration (Ames If aneuploidy were simply the consequence of the neoand Gold, 1990; Cohen and Ellwein, 1990) . We hypotheplastic factors described above, it should be found in size that in cells in which mutations of growth controlling colorectal tumors with MMR deficiency as often as in genes occur, apoptosis results and prevents such cells other colorectal tumors.
from proliferating. Apoptosis has been shown to be a Apart from differences in the type of genetic instability potent mechanism for killing cells receiving conflicting in tumors with MI, other important distinguishing feagrowth stimulatory and inhibitory signals (Bellamy et al., tures of these tumors have been described. MI-con-1995) . In MMR-deficient cells, the apoptosis would serve taining tumors have defects in HLA-locus genes, peras a safeguard to prevent neoplasia. In regenerating haps allowing them to evade the immune response that tissues, however, the apoptotic signals must be turned might be expected to be generated by tumors with multioff or the net cellular growth required for regeneration ple, random mutations (Branch et al., 1995) . Whether would be impossible. Mutations in growth-controlling colorectal tumors without MI have similar alterations genes in this environment would therefore lead to the in proteins participating in immune recognition is not initiation or progression of neoplasia, while in uninjured known. In addition, colorectal tumors are generally incells, the same mutations would simply result in cell sensitive to the growth-suppressing hormone TGF␤. In death. tumors with MI, this insensitivity is almost always due This argument is speculative but may help to explain to frameshift mutations within a microsatellite sequence some puzzling observations relating diet to colorectal embedded in the TGF␤ receptor II gene (Markowitz et cancer incidence. There is little question about the imal., 1995). In tumors without MI, mutations of this reportance of diet in limiting colorectal cancer incidence in ceptor have not been detected. Instead, the TGF␤ inthe Western world. It has been a reasonable assumption sensitivity in some of these cases probably results that the dietary components responsible were mutafrom mutations of human MAD homologs that transmit gens. However, examination of mutational spectra in growth-inhibitory signals from the TGF␤ receptors (Hahn colorectal cancers has provided little evidence to favor et Riggins et al., 1996) . specific mutagens as causative agents. The most char-A small fraction of many tumor types, in addition to acteristic mutations observed in p53 and APC genes, those of the colon, display some level of MI (summarized for example, are C-to-T transitions at CG dinucleotides in Dams et al., 1995) . In most of these tumors, the insta- (Harris and Hollstein, 1993) . Such mutations are characbility is considerably less pronounced than that obteristic of endogenous processes leading to the hyserved in colon tumors and is unlikely to be due to drolytic deamination of methylated C residues in the mismatch repair gene defects. A large fraction of these absence of mutagen exposure. In contrast, the mutaother types of tumors exhibit gross chromosomal tional spectra in cancers of the skin, liver, and lung are changes, but as in the colon, the mechanisms underlying characteristic of DNA damage associated with specific such abnormalities are unknown, representing a major environmental components (Harris and Hollstein, 1993) . challenge for the future.
Thus, it is possible that the dietary factors which lead to colorectal cancer are not mutagens, but rather irritants that lead to tissue regeneration. Dietary fibers may Mutagens and Cancer absorb these irritants, explaining part of their protective The normal tissues from HNPCC patients do not genereffect (Giovannucci and Willett, 1994) . This hypothesis ally display genetic instability or a biochemical defect is also consistent with the observation that the age of in MMR. However, a few HNPCC patients have been incidence of colorectal cancer appears to be decreasing identified that display elevated rates of mutations in their in HNPCC kindreds. The mutation rate in such MMRphenotypically normal cells, accompanied by a biodeficient cancers is already extremely high, and it is chemically detectable deficit in MMR (Parsons et al., unlikely that dietary mutagens could increase this rate 1995). This defect may be due to inheritance of a domisignificantly. However, these diets may have become nant negative mutation, whereas most MMR gene mutaprogressively more irritating to the bowel due to detions are null. The patients with such mutations are recreases in fiber and increases in other constituents over markably normal. In particular, while these patients the course of the last century. develop colorectal cancers at an early age, similar to that of other HNPCC patients, they do not display the exponential increase in cancer incidence that would be FAP Versus HNPCC predicted if acquisition of several somatic mutations Tumor evolution in the two inherited colorectal cancer was the only rate-limiting step required for cancer development. Similarly, mice with targeted disruptions of syndromes described above provide an illuminating immediate of these is improved diagnosis through genetic testing. Though the genes involved are known, development of practical methods for detecting germline alterations is not a simple matter. The genes are very large (APC) or multiple (MMR), and in both FAP and HNPCC the mutations are heterogenous. In FAP, the development of specific tests has been facilitated by the knowledge that virtually all mutations so far described result in truncations of the APC protein through point mutations creating nonsense codons or small insertions or deletions causing frameshifts (Table  1A) . Simple tests to detect such truncating mutations have been devised van der Luijt et al., 1994) . These involve the amplification of the APC transcript by RT-PCR and transcription and translation of the PCR product in vitro. Electrophoresis of the products of the reactions directly reveals truncated products when mutations exist. This assay detects mutations in ‫%58ف‬ of FAP kindreds. Similar tests reveal mutations in 50%-60% of HNPCC kindreds . do not have a greatly increased incidence of adenomas, in striking but many are likely to wish to be tested for such mutacontrast to FAP patients . But FAP and HNPCC tions. Combined with the insensitivity of present assays, patients both develop colorectal cancers at a median age of 42 this suggests that only a small fraction of patients who years, suggesting that tumor progression is as rate-limiting for cancer formation as is tumor initiation. might be tested for germline mutations will actually benefit from the test. In the remainder, the negative test results cannot be interpreted unambiguously, as they contrast (Figure 8 ). FAP is a disease caused by a faulty could represent either the absence of mutation or the gatekeeper, APC. This defect allows thousands of beinsensitivity of the assay. These arguments underscore nign tumors to form, but each of these tumors slowly the need to develop more sensitive and cost-effective progresses to malignancy, requiring the sequential actests for genetic diagnosis. They also underscore the cumulation of mutations in RAS, p53, etc. Because there necessity of performing such tests under the supervision are so many adenomas, however, at least some will of trained genetic counselors who can accurately comprogress to cancer. The median age of cancer diagnosis municate the implications of positive or negative tests in in untreated FAP patients is 42, 25 years earlier than a socially, medically, and psychologically sound fashion. the median age of sporadic colorectal cancer patients.
What are the ethical implications of such genetic testIn HNPCC, adenomas form at approximately the same ing? After all, neither HNPCC nor FAP is necessarily rate as in the general population. However, the adenoma lethal. Appropriate surveillance and surgical intervention cell with the MMR deficiency acquires mutations at a allows most patients to achieve normal life-spans, rate two to three orders of magnitude higher than in though with significant morbidity. Should prenatal testnormal cells, and the resultant accumulation of mutaing for such nonlethal disease be permitted? Should tions in oncogenes and tumor suppressor genes leads information on genetic susceptibility be communicated to a rapid progression to malignancy. This accelerated to employers, insurance companies, other family memrate of tumor progression is observed in mice with germbers, prospective spouses? These questions are difficult line mutations of the murine MSH2 gene as well as in and not limited to hereditary colorectal cancer-the humans with HNPCC Reitmair et al., identical issues are or will soon be faced with regards 1996).
to breast cancers, melanomas, and a variety of other Interestingly, cancer in HNPCC patients occurs at a median age of 42, the same age as in FAP patients.
common diseases with genetic components. FAP can therefore be considered as a disease of tumor Despite these problems, the positive attributes of geinitiation and HNPCC one of tumor progression. Initianetic testing for cancer susceptibility should not be untion and progression are of course the cardinal features derestimated. Family members who have tested negaof malignancy. Many carcinogenesis studies have tive for the particular APC or MMR gene mutation tended to focus on agents that initiate tumorigenesis. involved in their kindred will be spared the repeated The studies on HNPCC suggest that agents which accelmedical and endoscopic examinations that would othererate progression can be at least as important.
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